A detailed history of Prudent Investors Network, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Prudent Investors Network, Inc. holds 6,680 shares of ABBV stock, worth $1.34 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
6,680
Previous 5,930 12.65%
Holding current value
$1.34 Million
Previous $1.02 Million 29.7%
% of portfolio
0.41%
Previous 0.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $122,880 - $149,497
750 Added 12.65%
6,680 $1.32 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.02%
5,930 $1.02 Million
Q1 2024

May 16, 2024

BUY
$159.82 - $182.1 $5,753 - $6,555
36 Added 0.61%
5,929 $1.08 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $1,798 - $2,156
-13 Reduced 0.22%
5,893 $952,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $26,395 - $32,750
-200 Reduced 3.28%
5,906 $957,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $2,840 - $3,164
27 Added 0.44%
6,106 $688,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $42,761 - $47,075
418 Added 7.38%
6,079 $658,000
Q3 2020

Nov 03, 2020

SELL
$85.91 - $100.83 $31,185 - $36,601
-363 Reduced 6.03%
5,661 $495,000
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $54,807 - $73,340
-747 Reduced 11.03%
6,024 $591,000
Q1 2020

Apr 08, 2020

SELL
$64.5 - $97.79 $16,189 - $24,545
-251 Reduced 3.57%
6,771 $515,000
Q4 2019

Jan 30, 2020

BUY
$72.13 - $90.25 $506,496 - $633,735
7,022 New
7,022 $621,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prudent Investors Network, Inc. Portfolio

Follow Prudent Investors Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Investors Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Prudent Investors Network, Inc. with notifications on news.